Skip to main content

Table 2 Prevalence, cure rate and egg intensity at baseline, 6 weeks and 2 years following annual treatment with praziquantel

From: Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity

Variable

Baseline

6 weeks post treatment

2 years post treatment

Prevalence

Cure rate

49 (23.1%)

1 (0.47%)

98%

1 (0.47%)

97.8%

Boys

Cure rate

20 (19%)

1 (0.47%)

95%

1 (0.47%)

94.7%

Girls

Cure rate

29 (27.1%)

0

100%

0

100%

7–9

Cure rate

19 (20%)

1 (0.47%)

94.7%

1 (0.47%)

94.4%

10–13

Cure rate

30 (25.6%)

0

100%

0

100%

Eggs per 10 ml

15.9

3

2